Skip Navigation

European Heart Journal 2001 22(12):990-996; doi:10.1053/euhj.2000.2371
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Boriani, G
Right arrow Articles by Branzi, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boriani, G
Right arrow Articles by Branzi, A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical Perspectives

Cost-effectiveness of implantable cardioverter-defibrillators

G Borianif1, M Biffi, C Martignani, M Gallina and A Branzi

Institute of Cardiology, University of Bologna, Bologna, Italy

revised July 10, 2000; accepted July 12, 2000

Key Words: Antiarrhythmic drugs, cardioverter defibrillator, cost-effectiveness, sudden death, ventricular fibrillation, ventricular tachycardia

f1 Correspondence: Giuseppe Boriani, MD, FESC, Institute of Cardiology, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.

References

  1. Domanski MJ, Zipes DP, Schron E. Treatment of sudden cardiac death. Circulation. 1997;95:2694–2699[Free Full Text]
  2. Myerburg RJ, Interian A, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles at risk. Am J Cardiol. 1997;80:10F–19F[CrossRef][Medline]
  3. Wilber DJ, Koll JG, Kapp DE. What can we expect from prophylactic implantable cardioverter defibrillators? Am J Cardiol. 1997;80:20F–27F[CrossRef][Medline]
  4. Moss AJ, Hall J, Cannom DS. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933–1940[Abstract/Free Full Text]
  5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial investigators. N Engl J Med. 1999;341:1882–1890[Abstract/Free Full Text]
  6. Bigger JT, Fleiss JL, Kleiger L, Miller JP, Rolnitzky LP. The relationship among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Am J Cardiol. 1986;69:250–258
  7. Maggioni AP, Zuanetti G, Franzosi MG. Prevalence and prognostic significance of ventricular arrrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation. 1993;87:312–322[Abstract/Free Full Text]
  8. Marchlinski F, Buxton A, Waxman H, Josephson ME. Identifying patients at risk of sudden death after myocardial infarction. Am J Cardiol. 1983;52:1190–1196[CrossRef][ISI][Medline]
  9. Pedretti R, Etro MD, Laporta A, Sarzi Braga S, Carù B. Prediction of late arrhythmic events after acute myocardial infarction fremo combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricuar tachycardia. Am J Cardiol. 1993;71:1131–1141[CrossRef][ISI][Medline]
  10. Zoni Berisso M, Silvestri D. Risk stratification after myocardial infarction: what is the clinical usefulness of programmed ventricular stimulation? Raviele A. Cardiac arrhythmias. Milano: Springer Verlag; 1997. p. 213–221
  11. Sweeney MO, Ruskin JM. Mortality benefits and the implantable cardioverter defibrillator. Circulation. 1994;89:1851–1858[Abstract/Free Full Text]
  12. Naccarelli GV, Wolbrette DL, Dell'Orfano JT, Patel HM, Luck JC. A decade of clinical trial developments in postmyocardial infarction, congestive heart failure and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. J Cardiovasc Electrophys. 1998;9:864–891[ISI][Medline]
  13. Myerburg RJ, Mitrani R, Interian A, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials. Circulation. 1998;97:1514–1521[Free Full Text]
  14. Friedman PL, Stevenson WG. Unsustained ventricular tachycardia. To treat or not to treat? N Engl J Med. 1996;335:1984–1985[Free Full Text]
  15. Goldman L, Gordon DG, Rifkind BM. Cost and health implications of cholesterol lowering. Circulation. 1992;85:1960–1968[Abstract]
  16. Kupersmith J, Holmes-Rovner M, Rovner D, Gardiner J. Cost-effectiveness analysis in heart disease. Part II. Preventive therapies. Progr Cardiovasc Dis. 1995;37:243–271[CrossRef][ISI][Medline]
  17. Kupersmith J, Holmes-Rovner M, Rovner D, Gardiner J. Cost-effectiveness analysis in heart disease. Part III. Ischemia, congestive heart failure and arrhythmias. Progr Cardiovasc Dis. 1995;37:307–346[CrossRef][ISI][Medline]
  18. Kupersmith J. Cost-effective strategies in cardiology. Hurst JW. The Heart. Arteries and Veins. New York: McGraw Hill; 1998. p. 2557–2578
  19. Kuppermann M, Luce BR, McGovern B, Podrid PJ, Bigger JT, Ruskin JN. An analysis of the cost effectiveness of the implantable defibrillator. Circulation. 1990;81:91–100[Abstract/Free Full Text]
  20. Larsen GC, Manolis AS, Sonnenberg FA, Beshanski JR, Estes MNA, Pauker SG. Cost-effectiveness of the implantable cardioverter defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol. 1992;19:1323–1334[Abstract]
  21. Kupersmith J, Hogan A, Guerrero P. Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. Am Heart J. 1995;130:507–515[CrossRef][ISI][Medline]
  22. Wever EF, Hauer RNW, Schrijvers G. Cost-effectiveness of implantable cardioverter defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in post infarct sudden death survivors. Circulation. 1996;93:489–496[Abstract/Free Full Text]
  23. Owens DK, Sanders GD, Harris RA. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126:1–12[Abstract/Free Full Text]
  24. Larsen GC, McAnulty JH, Hallstrom A. Hospitalization charges in the antiarrythmics versus implantable defibrillators (AVID) trial: the AVID economic analysis study (Abstr). Circulation. 1997;96:I–77
  25. Mushlin AI, Hall J, Zwanziger J. The cost-effectiveness of implantable cardiac defibrillators: results from MADIT. Multicentre Automatic Defibrillator Trial. Circulation. 1998;97:2129–2135[Abstract/Free Full Text]
  26. Cardinal DS, Connelly DT, Steinhaus DM, Lemery R, Waters M, Foley L. Cost savings with nonthoracotomy implantable cardioverter-defibrillators. Am J Cardiol. 1996;78:1255–1259[CrossRef][ISI][Medline]
  27. Saksena S, Madan N, Lewis C. Implanted cardioverter defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Progr Cardiovasc Dis. 1996;38:445–454[CrossRef][ISI][Medline]
  28. Nisam S. Continuing evolution of implantable cardioverter-defibrillators: smaller size, longer life, improved cost-effectiveness. Vardas PE. Cardiac Arrhythmias, Pacing and Electrophysiology. Dordrecht: Kluwer Academic Publishers; 1998. p. 295–300
  29. Boriani G, Frabetti L, Biffi M, Sallusti L. Clinical experience with downsized lower energy output implantable cardioverter-defibrillators. Int J Cardiol. 1998;66:261–266[CrossRef][ISI][Medline]
  30. Hauer RNW, Derken R, Wever EFD. Can implantable cardioverter-defibrillator therapy reduce healthcare costs? Am J Cardiol. 1996;78:134–139[CrossRef][ISI][Medline]
  31. Anderson MH, Camm AJ. The implantable cardioverter defibrillator: economic issues. Singer I. Implantable cardioverter defibrillator. Armonk: Futura Publishing; 1994. p. 547–573
  32. Stanton MS, Bell GK. Economic outcomes of implantable cardioverter defibrillators. Circulation. 2000;101:1067–1074[Abstract/Free Full Text]
  33. Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med. 1997;336:332–336[Abstract/Free Full Text]
  34. Dittus RS, Roberts SD, Adolph RJ. Cost-effectiveness analysis of patient management alternatives after uncomplicated myocardial infarction: a model. J Am Coll Cardiol. 1987;10:869–878[Abstract]
  35. Fineberg HV, Scadden D, Goldman L. Care of patients with a low probability of acute myocardial infarction: cost-effectiveness of alternatives to coronary-care-unit admission. N Engl J Med. 1984;310:1301–1307[Abstract]
  36. Higgins SL. Impact of the multicenter Automatic Defibrillator implantation trail on implantable cardioverter defibrillator indication trends. Am J Cardiol. 1999;83:79D–82D[CrossRef][ISI][Medline]
  37. Boersma, H, Doornhos, G, Bloemberg, BPM, Wood, DA, Kromhout, D, Simoons, ML, Cardiovascular disease in Europe. European Registries of Cardiovascular Diseases and Patient Management, Sophie-Antipolis, European Society of Cardiology, 1999, 26, 7
  38. Ector H. Pacemakers and ICD's in Europe: results of the registry of the European Working Group on Cardiac pacing. G Ital Cardiol. 1998;28:176–184
  39. Ector H, Rickards F, Vardas P, Santini M, Sutton R, Kappenberger L. The registry of the European Working Group on Cardiac Pacing (Abstr). PACE. 1998;21:960
  40. Ector H, Rickards F, Kappenberger L. The registry of the European Working Group on Cardiac Pacing (Abstr). PACE. 1999;22:782

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart J SupplHome page
G. Boriani, R. Ricci, T. Toselli, R. Ferrari, A. Branzi, and M. Santini
Implantable cardioverter defibrillators: from evidence of trials to clinical practice
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I66 - I73.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Boriani, M. Biffi, C. Martignani, I. Mangat, F. Bokhari, D. Newman, M. Greene, V. Korley, and P. Dorian
Letter Regarding Article by Bokhari et al, "Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone: Eleven-Year Follow-Up of a Subset of Patients in the Canadian Implantable Defibrillator Study (CIDS)" * Response
Circulation, January 25, 2005; 111(3): e26 - e26.
[Full Text] [PDF]

Home page
 EuropaceHome page
M. Biffi, G. Boriani, M. Bertini, P. Silvestri, C. Martignani, and A. Branzi
Pacing with capture verification in candidates for resynchronisation therapy: A feasibility study
Europace, January 1, 2005; 7(3): 255 - 265.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
G. Boriani, A. Lubinski, A. Capucci, P. Niederle, Z. Kornacewicz-Jack, A.M. Wnuk-Wojnar, M. Borggrefe, J. Brachmann, M. Biffi, G.S. Butrous, et al.
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease
Eur. Heart J., December 1, 2001; 22(23): 2180 - 2191.
[Abstract] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Boriani, G
Right arrow Articles by Branzi, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boriani, G
Right arrow Articles by Branzi, A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?